Viewing Study NCT01531595


Ignite Creation Date: 2025-12-24 @ 1:32 PM
Ignite Modification Date: 2026-01-01 @ 6:56 AM
Study NCT ID: NCT01531595
Status: ACTIVE_NOT_RECRUITING
Last Update Posted: 2024-12-12
First Post: 2012-02-03
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Study of Bevacizumab in Combination with Alternating XELIRI and XELOX in Metastatic Colorectal Cancer
Sponsor: Pia Osterlund
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module